advertisement

---

Weigel M 1

Showing records 1 to 1 | Display all abstracts from Weigel M

75418 First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery
Pfeiffer N; Voykov B; Renieri G; Bell K; Richter P; Weigel M; Thieme H; Wilhelm B; Lorenz K; Feindor M; Wosikowski K; Janicot M; Päckert D; Römmich R; Mala C; Fettes P; Leo E
PLoS ONE 2017; 12: e0188899

---